margetuximab (MGAH 22) - MacroGenics
Margetuximab: Regulatory approval in US for 3/4 L HER2 positive metastatic breast cancer in 2020 (Macrogenics) - Jun 5, 2019 - ASCO 2019: Regulatory submission in EU in 3/4 L HER2 positive metastatic breast cancer in 2020 
BLA • European regulatory
http://ir.macrogenics.com/static-files/b2ab9a75-5559-4598-940f-15ba91ece878
 
Jun 5, 2019
 
 
db310ffd-0ab3-4b62-aff0-a97b5ca9d6ce.jpg